000797910 000__ 05857cam\a2200529Mu\4500
000797910 001__ 797910
000797910 005__ 20230306143455.0
000797910 006__ m\\\\\o\\d\\\\\\\\
000797910 007__ cr\cn\nnnunnun
000797910 008__ 170805s2017\\\\sz\\\\\\o\\\\\000\0\eng\d
000797910 019__ $$a999670478$$a1000018479
000797910 020__ $$a9783319561141$$q(electronic book)
000797910 020__ $$a3319561146$$q(electronic book)
000797910 020__ $$z9783319561134
000797910 020__ $$z3319561138
000797910 035__ $$aSP(OCoLC)ocn999655941
000797910 035__ $$aSP(OCoLC)999655941$$z(OCoLC)999670478$$z(OCoLC)1000018479
000797910 040__ $$aEBLCP$$beng$$cEBLCP$$dN$T$$dYDX$$dGW5XE$$dDKU$$dOCLCF$$dUAB
000797910 049__ $$aISEA
000797910 050_4 $$aRC280.U74
000797910 050_4 $$aR1
000797910 08204 $$a616.99/461$$223
000797910 08204 $$a616.6
000797910 24500 $$aPrinciples and practice of urooncology :$$bradiotherapy, surgery and systemic therapy /$$cGokhan Ozyigit, Ugur Selek, editors.
000797910 260__ $$aCham :$$bSpringer,$$c2017.
000797910 300__ $$a1 online resource (447 pages)
000797910 336__ $$atext$$btxt$$2rdacontent
000797910 337__ $$acomputer$$bc$$2rdamedia
000797910 338__ $$aonline resource$$bcr$$2rdacarrier
000797910 504__ $$aReferences
000797910 5050_ $$aPreface; Acknowledgments; Contents; List of Contributors; 1: Radiological Imaging in Urological Cancers; 1.1 Introduction; 1.2 Renal Cancer; 1.2.1 General Information; 1.2.2 Imaging Techniques; 1.2.2.1 Ultrasonography; 1.2.2.2 Computed Tomography; 1.2.2.3 Magnetic Resonance Imaging; Malignant Tumors of Renal Pelvis; Metastases; Lymphoma; Primary Renal Mesenchymal Tumors; 1.2.3 Staging of Renal Tumors; 1.2.4 Intervention in Renal Masses; 1.3 Bladder Cancer; 1.3.1 General Information; 1.3.2 Imaging Features; 1.3.2.1 Ultrasonography; 1.3.2.2 Computed Tomography
000797910 5058_ $$a1.3.2.3 Magnetic Resonance Imaging1.3.3 Staging; 1.3.3.1 Lymph Node Metastasis; 1.3.3.2 Metastasis Staging; 1.3.4 Monitoring After Treatment; 1.4 Prostate Cancer; 1.4.1 General Information; 1.4.2 Imaging Features; 1.4.2.1 Ultrasonography; 1.4.2.2 Computed Tomography; 1.4.2.3 Magnetic Resonance Imaging; 1.4.3 Local Staging of Patients with Biopsy-Proven Prostate Cancer; 1.4.3.1 Lymph Node Metastasis; 1.4.3.2 Distant Metastasis; 1.4.3.3 Preprocedural Assessment; 1.4.3.4 Metabolic Imaging; 1.4.3.5 Evaluation of Recurrence; References
000797910 5058_ $$a2: Management of Non-muscle-Invasive and Muscle-Invasive Bladder Cancers2.1 Introduction; 2.2 Management of Non-muscle-Invasive Bladder Cancer; 2.3 Repeat/Restaging Transurethral Resection; 2.4 Intravesical Chemotherapy; 2.5 Intravesical Immunotherapy; 2.6 Treatment Alternatives During the Global Shortage of BCG; 2.6.1 Alternative BCG Schedules; 2.6.2 Alternative Intravesical Chemotherapy Applications; 2.7 Future Perspectives; 2.8 Treatment of Disease Unresponsive to or Relapsing After BCG Vaccination; 2.9 Upfront Cystectomy for Very High-Risk NMIBC
000797910 5058_ $$a2.10 Surgical Management of Muscle-Invasive Bladder CancerReferences; 3: Target Volume Delineation Guidelines in Bladder Cancer; 3.1 Anatomy; 3.2 Role of Radiotherapy for Locoregional Disease; 3.3 Target Volume Delineation; 3.4 Definitive Radiotherapy for the Intact Bladder; 3.4.1 Gross Tumor Volume; 3.4.2 Clinical Target Volume; 3.4.3 Role of Elective Nodal Irradiation; 3.4.4 Planning Target Volume; 3.5 Adjuvant Setting; References; 4: Bladder Preservation Therapies in Bladder Cancer; 4.1 Introduction; 4.2 Management of Non-muscle-Invasive Bladder Cancer
000797910 5058_ $$a4.3 Treatment of Muscle-Invasive Disease4.3.1 Monotherapy; 4.3.2 Multimodal Approach; 4.4 Metastatic Disease and Recurrences; 4.5 Irradiation Techniques; 4.5.1 Simulation, Target Volume, and Fields; 4.5.2 Tumor Localization; 4.5.3 Target Delineation; 4.5.4 Doses and RT Schedules; 4.5.5 IMRT and IGRT; 4.5.6 Brachytherapy; References; 5: Systemic Therapy for Bladder Cancer; 5.1 Introduction; 5.2 Systemic Therapies in Muscle-Invasive Bladder Cancer; 5.3 Treatment of Advanced and Metastatic Disease; 5.3.1 DNA-Targeted Chemotherapy; 5.3.2 Targeted Therapies; 5.3.3 Immunotherapy
000797910 506__ $$aAccess limited to authorized users.
000797910 520__ $$aThis evidence-based, state of the art guide to the management of urological malignancies, including bladder cancer, prostate cancer, and testicular cancer, is designed to serve as an easy-to-consult reference that will assist in daily decision making and the delivery of optimal care for individual patients within a multidisciplinary setting. Readers will find up-to-date information on patient selection and the full range of treatment modalities, including modern radiotherapy techniques, systemic chemotherapy, surgical procedures (including robotic surgery and other minimally invasive approaches), hormonal therapies, immunotherapy, and focal therapies. With regard to radiotherapy, the coverage encompasses everything from delineation of tumor volumes and organs at risk based on CT simulation through to delivery of stereotactic body radiotherapy, intensity-modulated radiation therapy, tomotherapy, volumetric modulated arc therapy, and proton therapy. The authors are leading authorities with international reputations who have been selected for their expertise in the topic that they address. The book will be of value for all practicing urooncologists as well as other oncology fellows and residents interested in urooncology.
000797910 588__ $$aDescription based on print version record.
000797910 650_0 $$aUrinary organs$$xCancer.
000797910 7001_ $$aOzyigit, Gokhan.
000797910 7001_ $$aSelek, Ugur.
000797910 77608 $$iPrint version:$$aOzyigit, Gokhan$$tPrinciples and Practice of Urooncology : Radiotherapy, Surgery and Systemic Therapy$$dCham : Springer International Publishing,c2017$$z9783319561134
000797910 852__ $$bebk
000797910 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-56114-1$$zOnline Access$$91397441.1
000797910 909CO $$ooai:library.usi.edu:797910$$pGLOBAL_SET
000797910 980__ $$aEBOOK
000797910 980__ $$aBIB
000797910 982__ $$aEbook
000797910 983__ $$aOnline
000797910 994__ $$a92$$bISE